506 related articles for article (PubMed ID: 6192149)
1. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.
Shouval D; Rager-Zisman B; Quan P; Shafritz DA; Bloom BR; Reid LM
J Clin Invest; 1983 Aug; 72(2):707-17. PubMed ID: 6192149
[TBL] [Abstract][Full Text] [Related]
2. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
[TBL] [Abstract][Full Text] [Related]
3. Comparative morphology and tumourigenicity of human hepatocellular carcinoma cell lines in athymic rats and mice.
Shouval D; Schuger L; Levij IS; Reid LM; Neeman Z; Shafritz DA
Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):595-606. PubMed ID: 2452511
[TBL] [Abstract][Full Text] [Related]
4. hIFN-α gene modification augments human natural killer cell line anti-human hepatocellular carcinoma function.
Jiang W; Zhang C; Tian Z; Zhang J
Gene Ther; 2013 Nov; 20(11):1062-9. PubMed ID: 23759701
[TBL] [Abstract][Full Text] [Related]
5. A human hepatoma cell line (PCL/PRF/5) produces lung metastases and secretes HBsAg in nude mice.
Sattler FR; Paolucci S; Kreider JW; Ladda RL
Eur J Cancer Clin Oncol; 1982 Apr; 18(4):381-9. PubMed ID: 6889516
[TBL] [Abstract][Full Text] [Related]
6. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
7. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
[TBL] [Abstract][Full Text] [Related]
8. Suppression of HBsAg production in PLC/PRF/5 human hepatoma cell line by interferons.
Yamashita Y; Koike K; Takaoki M; Matsuda S
Microbiol Immunol; 1988; 32(11):1119-26. PubMed ID: 2464737
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis virus infection affects DNA methylation in mice with humanized livers.
Okamoto Y; Shinjo K; Shimizu Y; Sano T; Yamao K; Gao W; Fujii M; Osada H; Sekido Y; Murakami S; Tanaka Y; Joh T; Sato S; Takahashi S; Wakita T; Zhu J; Issa JP; Kondo Y
Gastroenterology; 2014 Feb; 146(2):562-72. PubMed ID: 24184133
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of type I and type III interferons in BNL hepatoma model.
Abushahba W; Balan M; Castaneda I; Yuan Y; Reuhl K; Raveche E; de la Torre A; Lasfar A; Kotenko SV
Cancer Immunol Immunother; 2010 Jul; 59(7):1059-71. PubMed ID: 20217081
[TBL] [Abstract][Full Text] [Related]
11. Mode of regulation of natural killer cell activity by interferon.
Minato N; Reid L; Cantor H; Lengyel P; Bloom BR
J Exp Med; 1980 Jul; 152(1):124-37. PubMed ID: 6156979
[TBL] [Abstract][Full Text] [Related]
12. Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice.
Reid LM; Minato N; Gresser I; Holland J; Kadish A; Bloom BR
Proc Natl Acad Sci U S A; 1981 Feb; 78(2):1171-5. PubMed ID: 6165008
[TBL] [Abstract][Full Text] [Related]
13. Induction of immune tolerance toward tumor-associated-antigens enables growth of human hepatoma in mice.
Gotsman I; Israeli D; Alper R; Rabbani E; Engelhardt D; Ilan Y
Int J Cancer; 2002 Jan; 97(1):52-7. PubMed ID: 11774243
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in nude mice of human hepatoma using monoclonal antibodies against hepatitis B virus.
Shouval D; Shafritz DA; Zurawski VR; Isselbacher KJ; Wands JR
Nature; 1982 Aug; 298(5874):567-9. PubMed ID: 7099252
[TBL] [Abstract][Full Text] [Related]
15. Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.
Shouval D; Wands JR; Zurawski VR; Isselbacher KJ; Shafritz DA
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):650-4. PubMed ID: 6952217
[TBL] [Abstract][Full Text] [Related]
16. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
Zheng M; Sun R; Wei H; Tian Z
J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hepatocellular carcinoma proliferation and hepatitis B surface antigen secretion with interferon-λ1 or PEG-interferon-λ1.
Tian S; Hui X; Fan Z; Li Q; Zhang J; Yang X; Ma X; Huang B; Chen D; Chen H
FASEB J; 2014 Aug; 28(8):3528-39. PubMed ID: 24769671
[TBL] [Abstract][Full Text] [Related]
18. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
19. hIL-15 gene-modified human natural killer cells (NKL-IL15) augments the anti-human hepatocellular carcinoma effect in vivo.
Jiang W; Zhang C; Tian Z; Zhang J
Immunobiology; 2014 Jul; 219(7):547-53. PubMed ID: 24721706
[TBL] [Abstract][Full Text] [Related]
20. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]